These instabilities are likely to occur in COVID-19 patients, with heart failure, hypertension, and arrhythmias, which stress the myocardial cytoskeletal network, and which have been correlated with cTnI and cTnT release [14,15]. This evidence concerns the gene TNNI3 and COVID-19.